Venomous creatures have long captivated the imagination, but Mandë Holford, a renowned scientist, has taken this fascination to a new level. Her journey into the world of venom began with a simple video of a marine snail hunting fish, which sparked her interest in the lethal power of nature's creations. This curiosity led her to pursue a career in chemistry and biology, ultimately shaping her research focus on venomous sea snails and cephalopods, and their potential as a source of life-saving medicines.
Holford's fascination with natural history began at a young age, thanks to her parents' frequent visits to the American Museum of Natural History in Manhattan. This early exposure to the wonders of the natural world laid the foundation for her future scientific endeavors. However, it wasn't until her undergraduate years that she discovered her passion for science, thanks to a chemistry professor who introduced her to the world of peptides and their potential in human physiology.
Her academic journey took her to various institutions, including the University of Utah, where she worked with Baldomero "Toto" Olivera, a pioneer in the study of predatory cone snails. Holford's research focused on the Terebridae, a family of marine gastropods known for their venomous abilities. She identified species with venom-producing glands and explored the chemical warfare tactics employed by these creatures.
Venom, an ancient evolutionary innovation, has evolved independently in numerous lineages, with an estimated 220,000 known venomous animal types. Holford's research agenda, aptly named "Mollusks to Medicine," aims to uncover the molecular secrets of venom and harness them for human benefit. She emphasizes the potential of venom peptides in drug discovery, as they reveal chemical pathways to manipulate cellular biology.
One of Holford's notable discoveries was the ability of a terebrid snail peptide, Tv1, to inhibit liver cancer cell proliferation. This finding has led to patenting and further research into potential therapies. Her team has also made significant contributions to the field, with seven FDA-approved drugs derived from venom, including Ziconotide, derived from the cone snail Conus magus, and Ozempic, from the Gila monster's saliva venom.
Holford's current research at Harvard involves designing organoids to study venom production and the development of venom-making glands. She also launched VenomsBase, a platform to integrate venom data and foster open research. Her passion for science extends beyond the lab, as she founded Killer Snails, an initiative to create immersive science curricula for students and promote underrepresented groups in science.
In conclusion, Mandë Holford's work showcases the incredible potential of nature's venom as a source of medical breakthroughs. Her dedication to exploring this fascinating field not only contributes to scientific advancements but also inspires a new generation of scientists, ensuring a brighter and healthier future for all.
